Advanced Search

 

Study ID Status Title Patient Level Data
110806 Completed Evaluation of GSK Biologicals’ dTpa booster vaccine in young adults 10 years after previous dTpa boosting. Study Listed on ClinicalStudyDataRequest.com
110808 Completed Primary vaccination course in children receiving the pneumococcal vaccine GSK 1024850A or Prevenar™ co-administered with Hiberix™ Study Listed on ClinicalStudyDataRequest.com
110825 Completed A Single Center, Single Sequence, Open-Label, Repeat-Dose Study to Investigate the Effect of XXX investigational drug on Hepatic Cytochrome P450 Activity in Healthy Adult Subjects
110833 Terminated A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects with Major Depressive Disorder
110847 Completed Observer blind immunogenicity and safety study of GlaxoSmithKline Biologicals' influenza vaccine GSK576389A with various formulations in adults aged 65 years and above Study Listed on ClinicalStudyDataRequest.com
110852 Completed MD7110852, A Phase 2b Dose-Ranging Study of Pazopanib Eye Drops versus Ranibizumab Intravitreal Injections for the Treatment of Neovascular Age-Related Macular Degeneration
110870 Completed Immunogenicity and safety study of a booster dose of GSK Biologicals’ meningococcal vaccine 134612 given at 12-15 months of age or at 15-18 months of age (co-administered with Infanrix®) in primed healthy toddlers. Study Listed on ClinicalStudyDataRequest.com
110876 Completed Immunogenicity & safety study of GSK Biologicals’ combined measles-mumps-rubella-varicella vaccine 208136 Study Listed on ClinicalStudyDataRequest.com
110882 Completed An open-label, randomized, single dose, five-period crossover study to evaluate the relative bioavailability of different formulations of GSK1838262 in healthy volunteers.
110886 Completed Immunogenicity and safety study of GSK Biologicals' HPV vaccine (GSK-580299) co-administered with a commercially available vaccine in healthy female adolescents Study Listed on ClinicalStudyDataRequest.com
110913 Active not recruiting A Phase III, Open Label, Randomized Trial of Ofatumumab Added to Fludarabine-Cyclophosphamide vs. Fludarabine-Cyclophosphamide Combination in Subjects with Relapsed Chronic Lymphocytic Leukemia
110921 Completed A Phase II Trial of Ofatumumab in Subjects with Waldenstrom's Macroglobulinemia
110927 Completed A Single Arm, Safety and Efficacy Study of Ofatumumab in Combination with ICE or DHAP Chemotherapy in Relapsed or Refractory Aggressive Lymphoma Prior to Autologous Stem Cell Transplantation
110928 Ofatumumab versus Rituximab Salvage Chemoimmunotherapy followed by Autologous Stem Cell Transplant (ASCT) in Relapsed or Refractory Diffuse Large B Cell Lymphoma (DLBCL)
110928 Ofatumumab versus Rituximab Salvage Chemoimmunotherapy followed by Autologous Stem Cell Transplant (ASCT) in Relapsed or Refractory Diffuse Large B Cell Lymphoma (DLBCL)
110932 Completed A Dose Finding Study of GSK716155 versus Placebo in the Treatment of Type 2 Diabetes Mellitus Study Listed on ClinicalStudyDataRequest.com
110946 Completed A three-way incomplete block crossover study to investigate the 24-hour pulmonary function of three dosage strengths of Fluticasone Furoate (FF)/GW642444 Inhalation Powder vs. Placebo, in subjects with Chronic Obstructive Pulmonary Disease (COPD) Study Listed on ClinicalStudyDataRequest.com
110947 Completed Evaluation of GSK Biological’s dTpa-IPV booster vaccine in children and adolescents, 5 years after previous dTpa-IPV boosting. Study Listed on ClinicalStudyDataRequest.com
110948 Completed Assessment of the effect of sumatriptan and naproxen sodium combination tablet, sumatriptan tablet, and naproxen sodium tablet treatment on blood pressure when administered intermittently for six months for the acute treatment of migraine attacks, with or without aura, in adults Study Listed on ClinicalStudyDataRequest.com
110951 Completed A two-part, randomised, placebo-controlled study to investigate the safety, tolerability, pharmacokinetics and pharmacodynamicsof single and repeat doses of intravenously infused GSK1995057 in healthy subjects. Study Listed on ClinicalStudyDataRequest.com
110963 Completed A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of XP13512 in Patients With Restless Legs Syndrome.
110978 Completed A Randomized, Double-Blind, Double Dummy, Comparative, Multicenter Study to Assess the Safety and Efficacy of Topical Retapamulin Ointment, 1%, versus Oral Linezolid in the Treatment of Secondarily-Infected Traumatic Lesions and Impetigo Due to Methicillin-Resistant Staphylococcus aureus Study Listed on ClinicalStudyDataRequest.com
111035 Completed A Randomized, Multicenter, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Oral Sumatriptan for the Acute Treatment of Migraine in Children and Adolescents Study Listed on ClinicalStudyDataRequest.com
111081 Completed A Multicentre, Single Arm, Observational Phase IV Study to Assess the Safety and Efficacy of Nelarabine in Children and Young Adults (up to 21 Years of Age) with Relapsed or Refractory T-Lineage Acute Lymphoblastic Leukaemia or Lymphoblastic Lymphoma
111086 Completed Health state utilities and health-related quality of life in chronic hepatitis B patients in Korea

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.